These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35888555)

  • 1. The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review.
    Liu X; Huang L; Liu M; Wang Z
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity, aberrant methylation, BRAF mutation and KRAS mutation in colorectal signet ring cell carcinoma.
    Kakar S; Deng G; Smyrk TC; Cun L; Sahai V; Kim YS
    Mod Pathol; 2012 Jul; 25(7):1040-7. PubMed ID: 22522845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
    Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
    Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
    Ogino S; Brahmandam M; Cantor M; Namgyal C; Kawasaki T; Kirkner G; Meyerhardt JA; Loda M; Fuchs CS
    Mod Pathol; 2006 Jan; 19(1):59-68. PubMed ID: 16118624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
    Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
    Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.
    Wei Q; Wang X; Gao J; Li J; Li J; Qi C; Li Y; Li Z; Shen L
    PLoS One; 2016; 11(6):e0156659. PubMed ID: 27300552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance and molecular features of signet-ring cell and mucinous components in colorectal carcinoma.
    Inamura K; Yamauchi M; Nishihara R; Kim SA; Mima K; Sukawa Y; Li T; Yasunari M; Zhang X; Wu K; Meyerhardt JA; Fuchs CS; Harris CC; Qian ZR; Ogino S
    Ann Surg Oncol; 2015 Apr; 22(4):1226-1235. PubMed ID: 25326395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and Corresponding Genetic Features of Colorectal Signet Ring Cell Carcinoma.
    Tajiri K; Sudou T; Fujita F; Hisaka T; Kinugasa T; Akagi Y
    Anticancer Res; 2017 Jul; 37(7):3817-3823. PubMed ID: 28668881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the molecular associations of mucinous colorectal cancer.
    Reynolds IS; Furney SJ; Kay EW; McNamara DA; Prehn JHM; Burke JP
    Br J Surg; 2019 May; 106(6):682-691. PubMed ID: 30945755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort.
    Allart M; Leroy F; Kim S; Sefrioui D; Nayeri M; Zaanan A; Rousseau B; Ben Abdelghani M; de la Fouchardière C; Cacheux W; Legros R; Louafi S; Tougeron D; Bouché O; Fares N; Roquin G; Bignon AL; Maillet M; Pozet A; Hautefeuille V;
    Dig Liver Dis; 2022 Mar; 54(3):391-399. PubMed ID: 34384712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
    Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
    Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and Molecular Characteristics of Colorectal Signet Ring Cell Carcinoma: A Review.
    An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
    Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of KRAS and BRAF in stage I-III colorectal cancer. A systematic review.
    Gallo G; Sena G; Vescio G; Papandrea M; Sacco R; Trompetto M; Sammarco G
    Ann Ital Chir; 2019; 90():127-137. PubMed ID: 30739887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Molecular Subtypes of Colorectal Tumors and Patient Survival, Based on Pooled Analysis of 7 International Studies.
    Phipps AI; Alwers E; Harrison T; Banbury B; Brenner H; Campbell PT; Chang-Claude J; Buchanan D; Chan AT; Farris AB; Figueiredo JC; Gallinger S; Giles GG; Jenkins M; Milne RL; Newcomb PA; Slattery ML; Song M; Ogino S; Zaidi SH; Hoffmeister M; Peters U
    Gastroenterology; 2020 Jun; 158(8):2158-2168.e4. PubMed ID: 32088204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum.
    Kawabata Y; Tomita N; Monden T; Ohue M; Ohnishi T; Sasaki M; Sekimoto M; Sakita I; Tamaki Y; Takahashi J; Yagyu T; Mishima H; Kikkawa N; Monden M
    Int J Cancer; 1999 Feb; 84(1):33-8. PubMed ID: 9988229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.
    Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
    Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes of colorectal cancers determined by PCR-based analysis.
    Sugai T; Eizuka M; Takahashi Y; Fukagawa T; Habano W; Yamamoto E; Akasaka R; Otuska K; Matsumoto T; Suzuki H
    Cancer Sci; 2017 Mar; 108(3):427-434. PubMed ID: 28083970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite instability-low colorectal cancer acquires a KRAS mutation during the progression from Dukes' A to Dukes' B.
    Asaka S; Arai Y; Nishimura Y; Yamaguchi K; Ishikubo T; Yatsuoka T; Tanaka Y; Akagi K
    Carcinogenesis; 2009 Mar; 30(3):494-9. PubMed ID: 19147861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.